Probation officials and a judge weren't impressed with the "Pharma bro," who's now a convicted fraudster.
A federal study found Gilead's remdesivir cut recovery time in some COVID-19 patients.
For virally-suppressed HIV-positive people, Cabenuva could replace a daily pill.
A 62-year-old Spanish man recovered from COVID-19 after he was treated with a drug cocktail that included HIV meds.
After being denied by the Global Fund to Fight AIDS, where can Venezuelans living with HIV turn for help?
New guidelines recommend immediate antiretroviral therapy for all HIV-positive people, and PrEP for those at risk.
A new study suggests half of the country's poz community isn't getting the antiretroviral therapy essential for positive health outcomes.